| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9155449 | American Heart Journal | 2005 | 8 Pages |
Abstract
The favorable clinical outcomes demonstrated for enoxaparin arm relative to the unfractionated heparin arm in ASSENT-3 were accompanied by a favorable distribution of costs and support the designation of this regimen as economically attractive by conventional benchmarks.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Padma PhD, Paul W. MD, Patricia A. PhD, Eric L. DBA, Christopher B. MD, Frans MD, PhD, Daniel B. MD, MPH,